Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2004
11/24/2004CN1548076A Liquid composition prepn of magnesium salt and blood circulation promoting and blood clots dispersing Chinese medicine
11/24/2004CN1548056A Application of chitin, chitosan and their derivatives in preparing antiviral
11/24/2004CN1548055A Transdermic administrated external-use medicine composition
11/24/2004CN1548054A Medicine for preventing and treatig SARS coronavirus
11/24/2004CN1548053A New use of baicalin as medicine for treating anxiety neurosis
11/24/2004CN1548052A Application of aescin and its derivative in preparing medicine for treating acute pulmonary inflammation and hydrops
11/24/2004CN1548051A Tillering onion extract and its application
11/24/2004CN1548050A Sobering-up liver-protecting medicine composition for preventing chemical liver damage and its prepn process
11/24/2004CN1548048A Medicinal composition and tuchahoe extract for raising immunity
11/24/2004CN1548047A Cyclovirobuxine dripping pill and its prepn. process
11/24/2004CN1548046A Baicalin-zinc medicine
11/24/2004CN1548045A Externally applied Pioxican prepn and its prepn process
11/24/2004CN1548044A Fumaric acid-ketotifen dispersion tablet and its prepn process
11/24/2004CN1548043A Secnidazole injection and its prepn process
11/24/2004CN1548042A Prepn process and formulation of compound Meclofenoxate-Piracetam prepn
11/24/2004CN1548041A Andrographis herb prepn and its prepn process and application in preparing medicine
11/24/2004CN1548040A Application of skullcap root extract in preparing medicine for nasopharyngeal carcinoma
11/24/2004CN1548039A Red sage dripping pill and its prepn
11/24/2004CN1548038A New acetaminophen prepn
11/24/2004CN1548037A Asafetida extract and its pharmaceutical use
11/24/2004CN1548036A Medicine containing acarnine compound as active component
11/24/2004CN1177043C Acidophilic thermostable mycose-base synthetase and its prepn and use
11/24/2004CN1177002C Antimicrobial composition
11/24/2004CN1176937C Double-stranded RNA and use thereof
11/24/2004CN1176936C Chaplamycin derivative and medicinal composition containing the same
11/24/2004CN1176933C Magnesium zinc fructose diphosphate and its preparing process and application in preparing medicines
11/24/2004CN1176932C Zinc fructose-diphosphate and its preparing process and application
11/24/2004CN1176922C 8-quinolinxanthine and 8-isoquinolinxanthine derivs. as PDE 5 inhibitors
11/24/2004CN1176921C Semi-hydrochloride of 8-cyan-1-cyclopropyl-7-(1S-2,8-diazabicyclo [4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
11/24/2004CN1176916C Semi-synthetic taxanes with antitumor and antiangiogenetic activities
11/24/2004CN1176915C Alkynyl phenyl heteroaromatic glucokinase activators
11/24/2004CN1176914C Intermediate for preparing 10-deacetylation baccatin III and 10-deacetylation-14 beta hydroxy baccatin III derivatives
11/24/2004CN1176911C Benzidine-sulfuryl radical substitution pentatomic heterocycle, its preparation method, its medicinal and composition
11/24/2004CN1176910C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
11/24/2004CN1176909C Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of same
11/24/2004CN1176908C Process for producing pyridine derivate
11/24/2004CN1176902C New esters derived from substituted phenyl-cyclohexyl compounds
11/24/2004CN1176716C Composition for prevention and/or treatment of atheromatous arteriosclerosis
11/24/2004CN1176714C Method and composition for treating prostate cancer
11/24/2004CN1176709C Drug for curing scald, wound as well as hemorrhoids
11/24/2004CN1176707C Guttate pills for treating obstruction of qi in the chest and chest pain and preparing process thereof
11/24/2004CN1176701C Aerosol for treating burn and scald, and its prepn-process
11/24/2004CN1176688C Medicine for treating acute and chronic pharyngitis and its prepn
11/24/2004CN1176676C Blood circulation activating and pain stopping ointment for treating bone injury and its prepn process
11/24/2004CN1176673C Compound ant powder prescription
11/24/2004CN1176672C Face-beautifying ointment and its preparing process
11/24/2004CN1176669C Immune regulator of amino acid calcium from turtle shell and its preparation
11/24/2004CN1176661C Gene medicine against mammitis of dairy cow
11/24/2004CN1176660C Pharmaceutical application of froctose biphosphate magnesium
11/24/2004CN1176659C Fluticasone lotion having improved vasoconstrictor activity
11/24/2004CN1176658C Aseptic freeze-dried prostaglandin injection and its preparing method and use
11/24/2004CN1176657C Drug composition containing cefazolin and beta-lactamase inhibitor
11/24/2004CN1176656C Freeze-drying composition for injection
11/24/2004CN1176655C Refapentine or rifampin liposome perfusate, injection and preparation process thereof
11/24/2004CN1176654C Quinolinone derivative preparations and process for producing same
11/24/2004CN1176653C Slow-releasing Anixidan capsule
11/24/2004CN1176652C Application of demelani in diseases treatment
11/24/2004CN1176651C N-(3-benzofuryl) urea derivative
11/24/2004CN1176650C Use of balufen in preparation of medicine for treating nicotine depondence
11/24/2004CN1176649C Inhalant of Shumaputan dry-powder and its preparation method
11/24/2004CN1176648C Hawthorn leaves total flavone soft capsule and its preparing method
11/24/2004CN1176647C 间苯二酚衍生物 Resorcinol derivatives
11/23/2004WO2004103378A1 Immediate-release pharmaceutical dosage form comprising polymorphous tibolone
11/23/2004US6822120 Sulfone liver X-receptor modulators
11/23/2004US6822102 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of COX-2 mediated disorders
11/23/2004US6822100 Reacting n-sulfonyl-3-vinylindole with ruthenium complex in presence of ethyl diazoacetate and toluene; psychological, sexual, and eating disorders
11/23/2004US6822099 Method of resolving amlodipine racemate
11/23/2004US6822098 Carbocyclic carbo, oxo amines such as n-heptyl-3-methyl-4-oxo -1,4-dihydroquinoline-2-carboxamide, used for prophylaxis of gastrointerstinal disorders
11/23/2004US6822097 Compounds and methods of uses
11/23/2004US6822087 For anti-asthma/allergy/hypereosinophilia/inflammation/ cancer/tumor drugs; gene expression inhibition
11/23/2004US6822080 For identification/cloning/drug screening; enzyme inhibitors
11/23/2004US6822004 Primary aliphatic c24-30 alcohols from the wax secreted by the insect ericerus pela; tetracosanol, hexacosanol, octacosanol and triacontanol; treatment of obesity, syndrome x, diabetes, hypercholesterolemia, ischemia, thrombosis, atherosclerosis
11/23/2004US6822002 Use of L-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use
11/23/2004US6822001 Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
11/23/2004US6821999 Methods for inhibiting the production of TSST-1
11/23/2004US6821998 Arylamines as inhibitors of chemokine binding to US28
11/23/2004US6821997 Associated with a decreased presence of cell-specific carbonic anhydrase enzymes; neurodegenerative conditions, dementia, alzheimer's disease; administering compound to increase ca such as forms of zinc
11/23/2004US6821995 Method of treating batten disease
11/23/2004US6821991 2-substituted thiazolidinones as β-3 adrenergic receptor agonists
11/23/2004US6821990 Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5, 7-dihydroxy-8 [4R-(3S-hydroxy-1-M ethyl) piperidinyl]-4H-1-benzopyran-4-one
11/23/2004US6821989 Using a tamoxifen type compound
11/23/2004US6821988 3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases
11/23/2004US6821987 4-substituted by azolylureido-phenoxy, or phenylthio; antitumor agents; treating diabetic retinopathy, chronic rheumatism, psoriasis, atherosclerosis,
11/23/2004US6821986 Drugs such as (2s)-2-amino-n-(4-anilinophenyl)-5-((imino(2-oxido-2 -oxohydrazino)methyl)amino) pentanamide, used as nitric oxide synthase inhibitors, free radical scavangers or as antioxidants
11/23/2004US6821985 Administering an nr2b subtype selective n-methyl-d-aspartate (nmda) receptor antagonist with a thrombolytic agent for treating hypoxic or ischemic stroke
11/23/2004US6821984 Ring fused pyrazole derivatives as CRF antagonists
11/23/2004US6821981 For therapy of disorders, such as anxiety, aggression and stress, and for the control of various physiological phenomena, such as appetite, thermoregulation, sleep and sexual behavior
11/23/2004US6821980 Substituted 5-benzyl-2,4-diaminopyrimidines
11/23/2004US6821979 Synergistic enhancement of cognitive ability
11/23/2004US6821978 Xanthine phosphodiesterase V inhibitors
11/23/2004US6821977 Antidiabetic agents
11/23/2004US6821976 S-6-hydroxy-buspirone
11/23/2004US6821975 Beta-carboline drug products
11/23/2004US6821974 Vasodilation; hypotensive agents; cardiovascular disorders
11/23/2004US6821973 Compounds
11/23/2004US6821971 For prophyalxis of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease (ibs), septic shock, cardiopulmonary dysfunction, acute respiratory disease, cachexia
11/23/2004US6821970 Useful for treating diseases wherein modulation of 5-ht activity is desired; nervous system disorders
11/23/2004US6821968 Stable taurolidine electrolyte solutions
11/23/2004US6821967 Amines such as 9-(4-(4-(benzothiazol-2-yl)-piperazin-1-yl)-butyl)-9h-fluorene-9-carboxylic acid (2,2,2-trifluoroethyl) amide, used as microsomal triglyceride transfer protein antagonists, to prevent atherosclerosis or hyperlipemia
11/23/2004US6821966 Antiinflammatory agents